FMCG products maker Procter & Gamble Hygiene and Health Care Ltd posted a remarkable 36.44% increase in its post-tax profit, reaching INR 210.69 crore for the first quarter ending in September. This performance marks a significant improvement from the INR 154.41 crore profit reported during the corresponding quarter of the previous fiscal year for the company, which follows a financial year from July to June.
According to a regulatory filing, the company reported a 9.04% increase in net sales, amounting to INR 1,135.06 crore for the quarter under review, compared to INR 1,040.92 crore during the same period the previous year.
During the July-September period, the company’s revenue from operations stood at INR 1,138.35 crore, indicating an 8.94% increase compared to the corresponding period of the previous year.
In its earnings statement, the company attributed this rise to a “superior retail execution and integrated growth strategy.”
The “PAT (Profit After Tax) for the quarter was INR 211 crore, up 36 per cent versus year ago led by acceleration of volume growth coupled with product price-mix and productivity,” it added.
The company, renowned for its popular brands like Vicks in healthcare and Whisper in feminine care, saw its total income increase by 9.74% to reach INR 1,154.12 crore.
In the September quarter, the company’s total expenses rose by 2.81% to reach INR 869.65 crore.
“We delivered a strong top and bottom line growth in the quarter by executing our integrated strategy of a focused product portfolio of daily use categories…,” the company’s Managing Director L V Vaidyanathan said.
On the BSE, the shares of Procter & Gamble Hygiene and Health Care Ltd dropped by 1.37% to close at INR 16,744.25 per share.